|
|
2GO53 |
|
Vaxjo ID |
139 |
|
Vaccine Adjuvant Name |
2GO53 |
|
Adjuvant VO ID |
VO_0005777
|
|
Description |
A vaccine adjuvant, a small molecule TLR agonist that drives a mixed Th1/Th2 response |
|
Stage of Development |
Research |
|
Location Licensed |
United States |
|
Host Species for Testing |
3 |
|
Storage |
Formulated material at 4C for 6 months Solid form is stable at 4C for > 2 years |
| References |
|
|
